Integrative development of smart drug-vector nanostructures for adaptive delivery to target cells

Project Information

VAHVISTUS

Grant agreement ID: 734759

DOI

10.3030/734759

Project closed

EC signature date 14 December 2016

Start date 1 March 2017

End date 28 February 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 1 012 500,00

EU contribution

€ 990 000,00

Coordinated by

HELSINGIN YLIOPISTO
Finland

• Smart new compounds target both tumours and tropical diseases
  DE EN ES FR IT PL